Literature DB >> 14987281

Immunohistochemical investigation of mid-dermal elastolysis.

T Gambichler1, F Breuckmann, A Kreuter, S Boms, P Altmeyer, M Stücker.   

Abstract

We report a 31-year-old Caucasian woman presenting with remarkable wrinkling on her trunk and proximal extremities. Diagnosis of mid-dermal elastolysis (MDE) was confirmed by Van Gieson's staining. Immunohistochemical investigations revealed enhanced expression of CD34+ and CD68+ cells accompanied by slightly increased expression of CD3+ and CD4+ lymphocytes in lesional skin. Furthermore an elevated cellular expression of matrix metalloproteinase (MMP)-1 and slightly increased presence of MMP-12 positive cells combined with a decrease of tissue inhibitor of metalloproteinases 1 (TIMP-1) positive cells was observed in lesional skin as compared with a control specimen obtained from nonlesional skin. Our data may indicate inflammatory processes and an altered balance between MMPs and TIMPs in MDE. Furthermore CD34+ dendritic fibroblasts and/or histiocytes are possibly involved in the pathogenesis of MDE.

Entities:  

Mesh:

Year:  2004        PMID: 14987281     DOI: 10.1111/j.1365-2230.2004.01480.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  4 in total

1.  [Subtle, circumscribed plications along Langer's lines].

Authors:  T Gambichler; S Boms; A Kreuter; P Altmeyer; M Stücker
Journal:  Hautarzt       Date:  2004-03       Impact factor: 0.751

2.  [Mid-dermal elastolysis].

Authors:  T Wiederholt; M Megahed
Journal:  Hautarzt       Date:  2007-05       Impact factor: 0.751

Review 3.  [Mid-dermal elastolysis].

Authors:  D Helbig; M Schlaak; R Renner; J C Simon; W Harth; U Paasch
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

Review 4.  Mid-dermal elastolysis: A female-centric disease; case report and updated review of the literature.

Authors:  Jori Hardin; Elaine Dupuis; Richard M Haber
Journal:  Int J Womens Dermatol       Date:  2015-07-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.